Showing results (91-100 of 139) with videos related to

Sort By:
Pageof 14
Frontiers in Oncology|June 5, 2026
Case Report: Patient-derived organoids guiding dabrafenib-trametinib therapy in BRAFV600E-mutant metastatic gastric cancerCaifeng Gong, Yang Yang, Qi Yan, et al.
BMC Medicine|August 22, 2023
Abnormal generation of IL-17A represses tumor infiltration of stem-like exhausted CD8+ T cells to demote the antitumor immunityRuochan Zhang, Kun Chen, Caifeng Gong, et al.
Frontiers in Immunology|January 27, 2022
Promising Immunotherapy in Metastatic Testicular Sex Cord Stromal Tumours After First-Line ChemotherapyBingqing Shang, Chuanzhen Cao, Weixing Jiang, et al.
International Journal of Surgery (London, England)|May 13, 2025
Neoadjuvant chemotherapy with albumin-bound paclitaxel plus cisplatin and capecitabine for locally advanced esophageal squamous cell carcinoma: a phase 2 clinical trialWen Zhang, Xiaowei Chen, Liyan Xue, et al.
Journal of Cellular Physiology|April 29, 2020
KIF15 promotes the evolution of gastric cancer cells through inhibition of reactive oxygen species-mediated apoptosisJinqiu Tao, Guangli Sun, Qing Li, et al.
Urologic Oncology|September 29, 2020
PD-L1 and VEGFR-2 expression in synchronous metastatic renal cell carcinoma treated with targeted therapy following cytoreductive nephrectomyWeixing Jiang, Dong Wang, Xiaoqi Liu, et al.
BMC Cancer|January 3, 2024
Regorafenib monotherapy or combined with an immune-checkpoint inhibitor as later-line treatment for metastatic colorectal cancer: a multicenter, real-world retrospective study in ChinaWang Qu, Zimin Liu, Xiaobing Chen, et al.
BMC Cancer|June 27, 2023
Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer to transform effectively EMVI and MRF from positive to negative: results of a long-term single center phase 2 clinical trialWen Zhang, Haitao Zhou, Jun Jiang, et al.
Clinical Nuclear Medicine|April 25, 2025
Comparison of Al 18 F-NOTA-FAPI-74 and 18 F-FDG PET/CT in the Evaluation and Staging of Hepatobiliary Malignancies : A Single-center Prospective StudyGuozhu Hou, Xin Cheng, Yuanyuan Jiang, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 30, 2021
Novel cut-off values of time from diagnosis to systematic therapy predict the overall survival and the efficacy of targeted therapy in renal cell carcinoma: A long-term, follow-up, retrospective studyChuanzhen Cao, Jianzhong Shou, Hongzhe Shi, et al.
Pageof 14